Current trends among pediatric ophthalmologists to decrease myopia progression-an international perspective.

Area of Science:

• Ophthalmology
• Pediatric Medicine
• Public Health

Background:

• Myopia (nearsightedness) is a growing global health concern, particularly in children.
• Effective strategies to slow myopia progression are crucial for long-term eye health.
• Understanding current clinical practices is essential for developing evidence-based guidelines.

Purpose of the Study:

• To investigate the current global preferred practice patterns of pediatric ophthalmologists for managing and reducing myopia progression in children.
• To identify the most frequently used treatments and lifestyle recommendations for myopia control.

Main Methods:

• A comprehensive questionnaire was distributed to members of international pediatric ophthalmology and strabismus societies.
• The survey assessed treatment initiation parameters, prescribed medications, and recommended behavioral interventions for myopia management.
• Response rates and statistical data were analyzed to determine prevailing practices.

Main Results:

• A high response rate (90.10%) indicated strong engagement from pediatric ophthalmologists.
• Over half (57%) routinely treat myopia progression, with a 1 diopter/year increase being the most common trigger for intervention.
• Low-concentration atropine eye drops (0.01%) were the most frequently prescribed pharmacological treatment, alongside recommendations for increased outdoor time and reduced screen use.

Conclusions:

• The majority of pediatric ophthalmologists actively manage myopia progression using diverse methods.
• Low-dose atropine (0.01%) is a widely adopted and safe treatment option.
• A significant lack of consensus exists regarding the optimal timing for initiating myopia control interventions.
• Further research is required to establish definitive treatment timing and assess the generalizability of findings across different ethnic populations to combat the myopia epidemic.